Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective and noncovalent inhibitors of oncogenic RAS mutants

Selective and noncovalent inhibitors of oncogenic RAS mutants

US Patent 12049483 · Granted Jul 30, 2024

Estimated economic value: $542,147,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods comprising antibodies that bind to covalent peptide con2025
Compositions and methods comprising antibodies that bind to covalent peptide con2025
Compositions and methods comprising antibodies that bind to covalent peptide con2025
Compositions and methods comprising antibodies that bind to covalent peptide con2025
Methods and composition involving thermophilic fibronectin type III (FN3) monobo2025
Methods and composition involving thermophilic fibronectin type III (FN3) monobo2025
Enhanced targeting platform2024
Enhanced targeting platform2024
Antibodies specific to delta 1 chain of T cell receptor2024
Antibodies specific to delta 1 chain of T cell receptor2024
Antibodies specific to delta 1 chain of T cell receptor2024
Liquid discharge head2023